Intravenous dexamethasone was already in short supply in US before the RECOVERY results came out, according to an independent shortage tracking tool run by the American Society of Health-System Pharmacists. FDA lists the drug as “in shortage” as well. https://t.co/Gk4mub7fCB
— ScienceInsider (@ScienceInsider) June 22, 2020